Ana Aguilar-Bonilla
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Neurofibromatosis and Schwannoma Cases, Cancer, Hypoxia, and Metabolism, Childhood Cancer Survivors' Quality of Life
Most-Cited Works
- → ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma(2024)74 cited
- → Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions(2024)10 cited
- → Fibroblast growth factor receptor 1 gene mutation as a potential risk factor for spontaneous intracranial hemorrhage in pediatric low-grade glioma patients(2024)2 cited
- → LG-72CYST RESPONSE TO BEVACIZUMAB IN PILOCYTIC ASTROCYTOMA: A CASE SERIES(2016)1 cited
- → EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS(2023)1 cited
- → NIMG-42. HOROS SOFTWARE FOR POSTOPERATIVE ANALYSIS OF PEDIATRIC HIGH-GRADE GLIOMAS(2020)1 cited
- → OTHR-10. COLLABORATIVE EFFORTS FOR HOSPITAL-BASED BIOBANK DEVELOPMENT AND OPTIMIZATION TO ENSURE QUALITY PEDIATRIC SPECIMENS FOR TRANSLATIONAL RESEARCH(2023)
- → EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY(2020)
- → EPEN-45. NORMALIZING AND FACILITATING GENOMIC TESTING AT DIAGNOSIS IN PEDIATRIC EPENDYMOMA(2020)
- → Supplementary Table S4 from Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions(2025)